Cell Phone Reminders Intervention

Completed · Not applicable

Conditions studied: HAART Non-Adherence, HIV, HIV Infections

In brief

This study will use a longitudinal, experimental design. Participants will be randomized to either the intervention or the control group. The intervention will involve cell phone support, including reminders, assessment of barriers to adherence, problem solving and referrals conducted by an Adherence Facilitator. Control group participants will participate in all on-study evaluations, except the intervention exit interviews.

Key facts

Study ID

NCT01049568

Run by

University of North Carolina, Chapel Hill

People needed

43

Starts

2009-10-01

Expected to finish

2010-11-01

Last updated by the study team

2017-02-28

Who can join

Age: 15 and older, up to 24. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Documented HIV-positive infected either behaviorally or perinatally as determined by medical record review or verbal verification from referring professional.
• Age 15 and 0 days to 24 years and 364 days. Enrolled in care at an AMTU or affiliated site.
• History of non-adherence to one or more components of antiretroviral therapy, defined as meeting one of the following criteria:
• Currently prescribed HAART and reports to care provider less than 90% adherence in previous month and has viral load greater than 1000 copies/ml when last evaluated (within the last four weeks);
• Discontinued HAART in the past while documented to be less than 90% adherent during the most recent antiretroviral treatment; and
• Agreed to initiate antiretroviral treatment in the past, but never initiated. Able to speak and understand English. Willing to provide informed consent or assent.

You may not qualify if…

• Evidence of cognitive impairment or other mental condition (including substance abuse) that limits his/her ability to complete intervention and assessments (per PI or designee discretion). Participants with stable and treated mental health/substance abuse disorders are acceptable for inclusion with protocol team approval.
• Any condition, including active substance abuse that is expected to limit the likelihood that the participant may maintain involvement for the entire year on-study (per PI or designee discretion with protocol team approval).
• No participant consent, parental permission or youth assent (as appropriate). Minors unable to acquire parental/guardian consent, even if not living at home, will not be able to participate as a change in housing status during the study might require premature discontinuation.
• Current participation in another behavioral interventional trial.

Where it is running

• Childrens Hospital of Los Angeles — Los Angeles, California, United States
• University of California San Francisco — San Francisco, California, United States
• Childrens National Medical Center — Washington D.C., District of Columbia, United States
• Children's Diagnostic and Treatment Center — Fort Lauderdale, Florida, United States
• Tulane University Health Sciences Center — New Orleans, Louisiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.